Phase I clinical trial to examine the safety of stereotactic radiotherapy including subclinical regions for pancreatic cancer
Phase 1
- Conditions
- Pancreatic cancer
- Registration Number
- JPRN-UMIN000044754
- Lead Sponsor
- Tohoku University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
Not provided
Exclusion Criteria
(1) A metallic stent has been inserted in the bile duct and duodenum. (2) Peritoneal dissemination has been confirmed by peritoneal cytology within 4 weeks prior to enrollment. (3) Cases with severe complication such as heart disease, renal disease, and hepatic disease (4) Fever over 38 degrees Celsius (5) Other active malignancy at the start of our study (6) Patients requiring systemic steroids medication or other immunosuppressants (7) Patients who can' t receive neither iodic drug nor gadolinium because of drug allergy (8) Cases with severe psychological disorder (9) Other cases that were judged to be inappropriate for conducting this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method